Mimitou, Eleni P.
Lareau, Caleb A. http://orcid.org/0000-0003-4179-4807
Chen, Kelvin Y. http://orcid.org/0000-0002-4406-2604
Zorzetto-Fernandes, Andre L.
Hao, Yuhan
Takeshima, Yusuke http://orcid.org/0000-0001-8312-9309
Luo, Wendy http://orcid.org/0000-0002-7041-823X
Huang, Tse-Shun http://orcid.org/0000-0001-8902-5439
Yeung, Bertrand Z.
Papalexi, Efthymia
Thakore, Pratiksha I.
Kibayashi, Tatsuya
Wing, James Badger http://orcid.org/0000-0002-3462-1003
Hata, Mayu
Satija, Rahul http://orcid.org/0000-0001-9448-8833
Nazor, Kristopher L.
Sakaguchi, Shimon
Ludwig, Leif S. http://orcid.org/0000-0002-2916-2164
Sankaran, Vijay G. http://orcid.org/0000-0003-0044-443X
Regev, Aviv http://orcid.org/0000-0003-3293-3158
Smibert, Peter http://orcid.org/0000-0003-0772-1647
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (HG0110014, HG-009748)
MEXT | Japan Society for the Promotion of Science (16H06295)
DH | NIHR | Health Services Research Programme (DK103794)
Article History
Received: 12 September 2020
Accepted: 16 April 2021
First Online: 3 June 2021
Competing interests
: C.A.L., L.S.L., V.G.S. and A.R. are listed as co-inventors on a patent related to mtscATAC-seq (U.S. provisional patent application 62/683,502). In the past 3 years, R.S. has worked as a consultant for Bristol-Myers Squibb, Regeneron and Kallyope and served as a scientific advisory board member for Immunai and Resolve BioSciences. A.R. is a founder and equity holder of Celsius Therapeutics, an equity holder in Immunitas Therapeutics and, until August 31, 2020, was a scientific advisory board member of Syros Pharmaceuticals, Neogene Therapeutics, Asimov and Thermo Fisher Scientific. From August 1, 2020, A.R. is an employee of Genentech. P.S. is listed as co-inventor on a patent related to this work (U.S. provisional patent application 62/515-180).